PCN56 NAB-PACLITAXEL OR DOCETAXEL; AS ALTERNATIVES TO CONVENTIONAL PACLITAXEL FOR THE TREATMENT OF METASTATIC BREAST CANCER (MBC)- A COST UTILITY ANALYSIS IN FIVE EUROPEAN COUNTRIES
May 1, 2008, 00:00
10.1016/S1098-3015(10)70234-5
https://www.valueinhealthjournal.com/article/S1098-3015(10)70234-5/fulltext
Title :
PCN56 NAB-PACLITAXEL OR DOCETAXEL; AS ALTERNATIVES TO CONVENTIONAL PACLITAXEL FOR THE TREATMENT OF METASTATIC BREAST CANCER (MBC)- A COST UTILITY ANALYSIS IN FIVE EUROPEAN COUNTRIES
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)70234-5&doi=10.1016/S1098-3015(10)70234-5
First page :
Section Title :
Open access? :
No
Section Order :
884